Bi-HPDO3A as a novel contrast agent for X-ray computed tomography.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 10 2023
05 10 2023
Historique:
received:
10
07
2023
accepted:
18
09
2023
medline:
1
11
2023
pubmed:
6
10
2023
entrez:
5
10
2023
Statut:
epublish
Résumé
A new bismuth-based CT agent was synthesized through a facile synthesis strategy. The in vitro stability, toxicity and CT performance were evaluated. The in vivo imaging performance was investigated using three different doses (0.5, 1.2 and 5 mmol/kg) and the result obtained at 1.2 mmol/kg was compared with the clinically approved CT agent iopamidol at the same dosage.
Identifiants
pubmed: 37798332
doi: 10.1038/s41598-023-43031-y
pii: 10.1038/s41598-023-43031-y
pmc: PMC10556142
doi:
Substances chimiques
Contrast Media
0
Bismuth
U015TT5I8H
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16747Informations de copyright
© 2023. Springer Nature Limited.
Références
Invest Radiol. 2022 Oct 1;57(10):629-638
pubmed: 35703267
Inorg Chem. 2003 Apr 7;42(7):2342-9
pubmed: 12665368
Chem Rev. 2013 Mar 13;113(3):1641-66
pubmed: 23210836
J Nanobiotechnology. 2020 Aug 6;18(1):110
pubmed: 32762751
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Chem Soc Rev. 2019 Jan 21;48(2):540-557
pubmed: 30499573
Nature. 2003 Apr 24;422(6934):876-8
pubmed: 12712201
Nat Mater. 2006 Feb;5(2):118-22
pubmed: 16444262
J Am Chem Soc. 2011 Apr 13;133(14):5508-15
pubmed: 21428437
Chem Commun (Camb). 2022 Jul 5;58(54):7466-7482
pubmed: 35730442
Pharmaceutics. 2021 Apr 21;13(5):
pubmed: 33919391
Microsc Res Tech. 2019 Jun;82(6):812-848
pubmed: 30786098
Nucl Med Biol. 2022 Nov-Dec;114-115:168-188
pubmed: 35753940
Front Oncol. 2022 Feb 18;12:813955
pubmed: 35251983
Clin Pharmacokinet. 1997 Mar;32(3):180-93
pubmed: 9084958
Org Biomol Chem. 2009 Sep 21;7(18):3810-6
pubmed: 19707687
Contrast Media Mol Imaging. 2010 Nov-Dec;5(6):305-8
pubmed: 20803503
Pharmaceutics. 2021 Oct 26;13(11):
pubmed: 34834207
Chem Rev. 1999 Sep 8;99(9):2601-58
pubmed: 11749495
Contrast Media Mol Imaging. 2013 Nov-Dec;8(6):475-86
pubmed: 24375903
Dalton Trans. 2008 Jun 21;(23):3027-47
pubmed: 18521444
Chem Soc Rev. 2021 Nov 1;50(21):12037-12069
pubmed: 34533144